KPIs & Operating Metrics(New)
Growth Metrics

AbbVie (ABBV) Share-based Compensation Growth (5y) (2017 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 10.54%
Dec 31, 2025 2.91%
Sep 30, 2025 5.23%
Jun 30, 2025 -5.38%
Mar 31, 2025 13.36%
Dec 31, 2024 15.73%
Sep 30, 2024 19.27%
Jun 30, 2024 20.17%
Mar 31, 2024 12.99%
Dec 31, 2023 12.30%
Sep 30, 2023 11.63%
Jun 30, 2023 16.06%
Mar 31, 2023 10.38%
Dec 31, 2022 11.38%
Sep 30, 2022 12.16%
Jun 30, 2022 7.08%
Mar 31, 2022 16.76%
Dec 31, 2021 11.46%
Sep 30, 2021 14.37%
Jun 30, 2021 3.02%
Mar 31, 2021 14.28%
Dec 31, 2020 20.74%
Sep 30, 2020 24.12%
Jun 30, 2020 33.82%
Mar 31, 2020 12.97%
Dec 31, 2019 12.94%
Sep 30, 2019 11.26%
Jun 30, 2019 12.17%
Mar 31, 2019 12.26%
Dec 31, 2018 13.60%
Sep 30, 2018 12.84%
Jun 30, 2018 13.07%
Mar 31, 2018 17.03%
Dec 31, 2017 19.96%
Sep 30, 2017 18.80%
Jun 30, 2017 16.77%
Mar 31, 2017 9.15%